ANZ JOURNAL OF SURGERY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=589406, encodeId=a3db5894067e, content=从投完稿到编辑做出决定之前一直都只显示under review152****8378暂无昵称 2020-04-21 00:00:00 发表: 想请问下，杂志显示Under review还是Under Review表示外审呢, beContent=152****8378暂无昵称 2020-04-21 00:00:00 发表: 想请问下，杂志显示Under review还是Under Review表示外审呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589397, encodeId=69ce58939eac, content=想请问下，杂志显示的Under review就是表示外审了吗？还是Under Review？183****6636暂无昵称 2020-04-06 00:00:00 发表: 感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, beContent=183****6636暂无昵称 2020-04-06 00:00:00 发表: 感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ba65088251, createdName=145c9b5bm78暂无昵称, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588314, encodeId=47b558831482, content=感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=675c2195011, createdName=120a0830m36暂无昵称, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581257, encodeId=750958125e05, content=投稿投了半年了，还没有任何消息，发了两次催稿信都说审稿人还没有返审稿意见，这审稿人是去度假还是干啥去了，坑的要死。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Tue Dec 10 00:00:00 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847865, encodeId=3a2984e865ba, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审稿挺快的，虽然分数不高，毕业用足够了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Thu Oct 25 17:12:59 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548711, encodeId=60d7548e11d0, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：7.11投.8.15一审结束.大修.说了80%拒稿.给到11.13返修结束.我10.26提交修改稿.10.28接收.感觉还是好中.关于一个良性肿瘤治疗策略的CASEs., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1dcd2010360, createdName=1e1eb212m21(暂无匿称), createdTime=Sun Oct 29 00:00:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548090, encodeId=519c548090a1, content=收稿一个多月后被拒，说拒搞率80%以上，文章内容不太符合他们主题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160527/IMG5747FCC4317196249.jpg, createdBy=f37a1729761, createdName=1dee57bam87(暂无匿称), createdTime=Tue Oct 10 17:11:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544745, encodeId=3558544e4590, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿1个月多点，被拒，回信说目前80%的拒稿率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39f52051168, createdName=atomins, createdTime=Mon Jul 24 10:56:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544744, encodeId=1b2a544e448a, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿1个月多点，被拒，回信说目前80%的拒稿率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39f52051168, createdName=atomins, createdTime=Mon Jul 24 10:56:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542130, encodeId=5900542130c9, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2020-04-21 追风雨看彩虹

从投完稿到编辑做出决定之前一直都只显示under review152****8378暂无昵称 2020-04-21 00:00:00 发表:
想请问下，杂志显示Under review还是Under Review表示外审呢

152****8378暂无昵称 2020-04-21 00:00:00 发表: 想请问下，杂志显示Under review还是Under Review表示外审呢

109 0

[GetPortalCommentsPageByObjectIdResponse(id=589406, encodeId=a3db5894067e, content=从投完稿到编辑做出决定之前一直都只显示under review152****8378暂无昵称 2020-04-21 00:00:00 发表: 想请问下，杂志显示Under review还是Under Review表示外审呢, beContent=152****8378暂无昵称 2020-04-21 00:00:00 发表: 想请问下，杂志显示Under review还是Under Review表示外审呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589397, encodeId=69ce58939eac, content=想请问下，杂志显示的Under review就是表示外审了吗？还是Under Review？183****6636暂无昵称 2020-04-06 00:00:00 发表: 感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, beContent=183****6636暂无昵称 2020-04-06 00:00:00 发表: 感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ba65088251, createdName=145c9b5bm78暂无昵称, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588314, encodeId=47b558831482, content=感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=675c2195011, createdName=120a0830m36暂无昵称, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581257, encodeId=750958125e05, content=投稿投了半年了，还没有任何消息，发了两次催稿信都说审稿人还没有返审稿意见，这审稿人是去度假还是干啥去了，坑的要死。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Tue Dec 10 00:00:00 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847865, encodeId=3a2984e865ba, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审稿挺快的，虽然分数不高，毕业用足够了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Thu Oct 25 17:12:59 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548711, encodeId=60d7548e11d0, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：7.11投.8.15一审结束.大修.说了80%拒稿.给到11.13返修结束.我10.26提交修改稿.10.28接收.感觉还是好中.关于一个良性肿瘤治疗策略的CASEs., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1dcd2010360, createdName=1e1eb212m21(暂无匿称), createdTime=Sun Oct 29 00:00:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548090, encodeId=519c548090a1, content=收稿一个多月后被拒，说拒搞率80%以上，文章内容不太符合他们主题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160527/IMG5747FCC4317196249.jpg, createdBy=f37a1729761, createdName=1dee57bam87(暂无匿称), createdTime=Tue Oct 10 17:11:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544745, encodeId=3558544e4590, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿1个月多点，被拒，回信说目前80%的拒稿率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39f52051168, createdName=atomins, createdTime=Mon Jul 24 10:56:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544744, encodeId=1b2a544e448a, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿1个月多点，被拒，回信说目前80%的拒稿率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39f52051168, createdName=atomins, createdTime=Mon Jul 24 10:56:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542130, encodeId=5900542130c9, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2020-04-21 145c9b5bm78暂无昵称

想请问下，杂志显示的Under review就是表示外审了吗？还是Under Review？183****6636暂无昵称 2020-04-06 00:00:00 发表:
感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。

183****6636暂无昵称 2020-04-06 00:00:00 发表: 感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。

94 0

[GetPortalCommentsPageByObjectIdResponse(id=589406, encodeId=a3db5894067e, content=从投完稿到编辑做出决定之前一直都只显示under review152****8378暂无昵称 2020-04-21 00:00:00 发表: 想请问下，杂志显示Under review还是Under Review表示外审呢, beContent=152****8378暂无昵称 2020-04-21 00:00:00 发表: 想请问下，杂志显示Under review还是Under Review表示外审呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589397, encodeId=69ce58939eac, content=想请问下，杂志显示的Under review就是表示外审了吗？还是Under Review？183****6636暂无昵称 2020-04-06 00:00:00 发表: 感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, beContent=183****6636暂无昵称 2020-04-06 00:00:00 发表: 感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ba65088251, createdName=145c9b5bm78暂无昵称, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588314, encodeId=47b558831482, content=感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=675c2195011, createdName=120a0830m36暂无昵称, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581257, encodeId=750958125e05, content=投稿投了半年了，还没有任何消息，发了两次催稿信都说审稿人还没有返审稿意见，这审稿人是去度假还是干啥去了，坑的要死。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Tue Dec 10 00:00:00 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847865, encodeId=3a2984e865ba, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审稿挺快的，虽然分数不高，毕业用足够了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Thu Oct 25 17:12:59 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548711, encodeId=60d7548e11d0, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：7.11投.8.15一审结束.大修.说了80%拒稿.给到11.13返修结束.我10.26提交修改稿.10.28接收.感觉还是好中.关于一个良性肿瘤治疗策略的CASEs., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1dcd2010360, createdName=1e1eb212m21(暂无匿称), createdTime=Sun Oct 29 00:00:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548090, encodeId=519c548090a1, content=收稿一个多月后被拒，说拒搞率80%以上，文章内容不太符合他们主题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160527/IMG5747FCC4317196249.jpg, createdBy=f37a1729761, createdName=1dee57bam87(暂无匿称), createdTime=Tue Oct 10 17:11:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544745, encodeId=3558544e4590, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿1个月多点，被拒，回信说目前80%的拒稿率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39f52051168, createdName=atomins, createdTime=Mon Jul 24 10:56:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544744, encodeId=1b2a544e448a, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿1个月多点，被拒，回信说目前80%的拒稿率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39f52051168, createdName=atomins, createdTime=Mon Jul 24 10:56:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542130, encodeId=5900542130c9, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2020-04-06 120a0830m36暂无昵称

感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。

89 0

[GetPortalCommentsPageByObjectIdResponse(id=589406, encodeId=a3db5894067e, content=从投完稿到编辑做出决定之前一直都只显示under review152****8378暂无昵称 2020-04-21 00:00:00 发表: 想请问下，杂志显示Under review还是Under Review表示外审呢, beContent=152****8378暂无昵称 2020-04-21 00:00:00 发表: 想请问下，杂志显示Under review还是Under Review表示外审呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589397, encodeId=69ce58939eac, content=想请问下，杂志显示的Under review就是表示外审了吗？还是Under Review？183****6636暂无昵称 2020-04-06 00:00:00 发表: 感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, beContent=183****6636暂无昵称 2020-04-06 00:00:00 发表: 感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ba65088251, createdName=145c9b5bm78暂无昵称, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588314, encodeId=47b558831482, content=感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=675c2195011, createdName=120a0830m36暂无昵称, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581257, encodeId=750958125e05, content=投稿投了半年了，还没有任何消息，发了两次催稿信都说审稿人还没有返审稿意见，这审稿人是去度假还是干啥去了，坑的要死。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Tue Dec 10 00:00:00 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847865, encodeId=3a2984e865ba, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审稿挺快的，虽然分数不高，毕业用足够了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Thu Oct 25 17:12:59 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548711, encodeId=60d7548e11d0, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：7.11投.8.15一审结束.大修.说了80%拒稿.给到11.13返修结束.我10.26提交修改稿.10.28接收.感觉还是好中.关于一个良性肿瘤治疗策略的CASEs., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1dcd2010360, createdName=1e1eb212m21(暂无匿称), createdTime=Sun Oct 29 00:00:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548090, encodeId=519c548090a1, content=收稿一个多月后被拒，说拒搞率80%以上，文章内容不太符合他们主题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160527/IMG5747FCC4317196249.jpg, createdBy=f37a1729761, createdName=1dee57bam87(暂无匿称), createdTime=Tue Oct 10 17:11:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544745, encodeId=3558544e4590, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿1个月多点，被拒，回信说目前80%的拒稿率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39f52051168, createdName=atomins, createdTime=Mon Jul 24 10:56:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544744, encodeId=1b2a544e448a, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿1个月多点，被拒，回信说目前80%的拒稿率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39f52051168, createdName=atomins, createdTime=Mon Jul 24 10:56:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542130, encodeId=5900542130c9, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2019-12-10 追风雨看彩虹

投稿投了半年了，还没有任何消息，发了两次催稿信都说审稿人还没有返审稿意见，这审稿人是去度假还是干啥去了，坑的要死。。。

92 0

[GetPortalCommentsPageByObjectIdResponse(id=589406, encodeId=a3db5894067e, content=从投完稿到编辑做出决定之前一直都只显示under review152****8378暂无昵称 2020-04-21 00:00:00 发表: 想请问下，杂志显示Under review还是Under Review表示外审呢, beContent=152****8378暂无昵称 2020-04-21 00:00:00 发表: 想请问下，杂志显示Under review还是Under Review表示外审呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589397, encodeId=69ce58939eac, content=想请问下，杂志显示的Under review就是表示外审了吗？还是Under Review？183****6636暂无昵称 2020-04-06 00:00:00 发表: 感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, beContent=183****6636暂无昵称 2020-04-06 00:00:00 发表: 感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ba65088251, createdName=145c9b5bm78暂无昵称, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588314, encodeId=47b558831482, content=感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=675c2195011, createdName=120a0830m36暂无昵称, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581257, encodeId=750958125e05, content=投稿投了半年了，还没有任何消息，发了两次催稿信都说审稿人还没有返审稿意见，这审稿人是去度假还是干啥去了，坑的要死。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Tue Dec 10 00:00:00 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847865, encodeId=3a2984e865ba, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审稿挺快的，虽然分数不高，毕业用足够了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Thu Oct 25 17:12:59 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548711, encodeId=60d7548e11d0, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：7.11投.8.15一审结束.大修.说了80%拒稿.给到11.13返修结束.我10.26提交修改稿.10.28接收.感觉还是好中.关于一个良性肿瘤治疗策略的CASEs., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1dcd2010360, createdName=1e1eb212m21(暂无匿称), createdTime=Sun Oct 29 00:00:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548090, encodeId=519c548090a1, content=收稿一个多月后被拒，说拒搞率80%以上，文章内容不太符合他们主题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160527/IMG5747FCC4317196249.jpg, createdBy=f37a1729761, createdName=1dee57bam87(暂无匿称), createdTime=Tue Oct 10 17:11:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544745, encodeId=3558544e4590, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿1个月多点，被拒，回信说目前80%的拒稿率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39f52051168, createdName=atomins, createdTime=Mon Jul 24 10:56:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544744, encodeId=1b2a544e448a, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿1个月多点，被拒，回信说目前80%的拒稿率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39f52051168, createdName=atomins, createdTime=Mon Jul 24 10:56:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542130, encodeId=5900542130c9, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2018-10-25 ms6459520362745523

审稿速度:6.0 | 投稿命中率:25.0
经验分享：审稿挺快的，虽然分数不高，毕业用足够了

61 0

[GetPortalCommentsPageByObjectIdResponse(id=589406, encodeId=a3db5894067e, content=从投完稿到编辑做出决定之前一直都只显示under review152****8378暂无昵称 2020-04-21 00:00:00 发表: 想请问下，杂志显示Under review还是Under Review表示外审呢, beContent=152****8378暂无昵称 2020-04-21 00:00:00 发表: 想请问下，杂志显示Under review还是Under Review表示外审呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589397, encodeId=69ce58939eac, content=想请问下，杂志显示的Under review就是表示外审了吗？还是Under Review？183****6636暂无昵称 2020-04-06 00:00:00 发表: 感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, beContent=183****6636暂无昵称 2020-04-06 00:00:00 发表: 感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ba65088251, createdName=145c9b5bm78暂无昵称, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588314, encodeId=47b558831482, content=感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=675c2195011, createdName=120a0830m36暂无昵称, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581257, encodeId=750958125e05, content=投稿投了半年了，还没有任何消息，发了两次催稿信都说审稿人还没有返审稿意见，这审稿人是去度假还是干啥去了，坑的要死。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Tue Dec 10 00:00:00 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847865, encodeId=3a2984e865ba, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审稿挺快的，虽然分数不高，毕业用足够了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Thu Oct 25 17:12:59 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548711, encodeId=60d7548e11d0, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：7.11投.8.15一审结束.大修.说了80%拒稿.给到11.13返修结束.我10.26提交修改稿.10.28接收.感觉还是好中.关于一个良性肿瘤治疗策略的CASEs., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1dcd2010360, createdName=1e1eb212m21(暂无匿称), createdTime=Sun Oct 29 00:00:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548090, encodeId=519c548090a1, content=收稿一个多月后被拒，说拒搞率80%以上，文章内容不太符合他们主题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160527/IMG5747FCC4317196249.jpg, createdBy=f37a1729761, createdName=1dee57bam87(暂无匿称), createdTime=Tue Oct 10 17:11:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544745, encodeId=3558544e4590, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿1个月多点，被拒，回信说目前80%的拒稿率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39f52051168, createdName=atomins, createdTime=Mon Jul 24 10:56:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544744, encodeId=1b2a544e448a, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿1个月多点，被拒，回信说目前80%的拒稿率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39f52051168, createdName=atomins, createdTime=Mon Jul 24 10:56:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542130, encodeId=5900542130c9, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2017-10-29 1e1eb212m21(暂无匿称)

审稿速度:2.0 | 投稿命中率:75.0
经验分享：7.11投.8.15一审结束.大修.说了80%拒稿.给到11.13返修结束.我10.26提交修改稿.10.28接收.感觉还是好中.关于一个良性肿瘤治疗策略的CASEs.

239 0

[GetPortalCommentsPageByObjectIdResponse(id=589406, encodeId=a3db5894067e, content=从投完稿到编辑做出决定之前一直都只显示under review152****8378暂无昵称 2020-04-21 00:00:00 发表: 想请问下，杂志显示Under review还是Under Review表示外审呢, beContent=152****8378暂无昵称 2020-04-21 00:00:00 发表: 想请问下，杂志显示Under review还是Under Review表示外审呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589397, encodeId=69ce58939eac, content=想请问下，杂志显示的Under review就是表示外审了吗？还是Under Review？183****6636暂无昵称 2020-04-06 00:00:00 发表: 感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, beContent=183****6636暂无昵称 2020-04-06 00:00:00 发表: 感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ba65088251, createdName=145c9b5bm78暂无昵称, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588314, encodeId=47b558831482, content=感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=675c2195011, createdName=120a0830m36暂无昵称, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581257, encodeId=750958125e05, content=投稿投了半年了，还没有任何消息，发了两次催稿信都说审稿人还没有返审稿意见，这审稿人是去度假还是干啥去了，坑的要死。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Tue Dec 10 00:00:00 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847865, encodeId=3a2984e865ba, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审稿挺快的，虽然分数不高，毕业用足够了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Thu Oct 25 17:12:59 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548711, encodeId=60d7548e11d0, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：7.11投.8.15一审结束.大修.说了80%拒稿.给到11.13返修结束.我10.26提交修改稿.10.28接收.感觉还是好中.关于一个良性肿瘤治疗策略的CASEs., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1dcd2010360, createdName=1e1eb212m21(暂无匿称), createdTime=Sun Oct 29 00:00:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548090, encodeId=519c548090a1, content=收稿一个多月后被拒，说拒搞率80%以上，文章内容不太符合他们主题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160527/IMG5747FCC4317196249.jpg, createdBy=f37a1729761, createdName=1dee57bam87(暂无匿称), createdTime=Tue Oct 10 17:11:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544745, encodeId=3558544e4590, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿1个月多点，被拒，回信说目前80%的拒稿率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39f52051168, createdName=atomins, createdTime=Mon Jul 24 10:56:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544744, encodeId=1b2a544e448a, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿1个月多点，被拒，回信说目前80%的拒稿率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39f52051168, createdName=atomins, createdTime=Mon Jul 24 10:56:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542130, encodeId=5900542130c9, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2017-10-10 1dee57bam87(暂无匿称)

收稿一个多月后被拒，说拒搞率80%以上，文章内容不太符合他们主题

246 0

[GetPortalCommentsPageByObjectIdResponse(id=589406, encodeId=a3db5894067e, content=从投完稿到编辑做出决定之前一直都只显示under review152****8378暂无昵称 2020-04-21 00:00:00 发表: 想请问下，杂志显示Under review还是Under Review表示外审呢, beContent=152****8378暂无昵称 2020-04-21 00:00:00 发表: 想请问下，杂志显示Under review还是Under Review表示外审呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589397, encodeId=69ce58939eac, content=想请问下，杂志显示的Under review就是表示外审了吗？还是Under Review？183****6636暂无昵称 2020-04-06 00:00:00 发表: 感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, beContent=183****6636暂无昵称 2020-04-06 00:00:00 发表: 感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ba65088251, createdName=145c9b5bm78暂无昵称, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588314, encodeId=47b558831482, content=感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=675c2195011, createdName=120a0830m36暂无昵称, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581257, encodeId=750958125e05, content=投稿投了半年了，还没有任何消息，发了两次催稿信都说审稿人还没有返审稿意见，这审稿人是去度假还是干啥去了，坑的要死。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Tue Dec 10 00:00:00 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847865, encodeId=3a2984e865ba, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审稿挺快的，虽然分数不高，毕业用足够了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Thu Oct 25 17:12:59 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548711, encodeId=60d7548e11d0, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：7.11投.8.15一审结束.大修.说了80%拒稿.给到11.13返修结束.我10.26提交修改稿.10.28接收.感觉还是好中.关于一个良性肿瘤治疗策略的CASEs., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1dcd2010360, createdName=1e1eb212m21(暂无匿称), createdTime=Sun Oct 29 00:00:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548090, encodeId=519c548090a1, content=收稿一个多月后被拒，说拒搞率80%以上，文章内容不太符合他们主题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160527/IMG5747FCC4317196249.jpg, createdBy=f37a1729761, createdName=1dee57bam87(暂无匿称), createdTime=Tue Oct 10 17:11:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544745, encodeId=3558544e4590, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿1个月多点，被拒，回信说目前80%的拒稿率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39f52051168, createdName=atomins, createdTime=Mon Jul 24 10:56:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544744, encodeId=1b2a544e448a, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿1个月多点，被拒，回信说目前80%的拒稿率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39f52051168, createdName=atomins, createdTime=Mon Jul 24 10:56:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542130, encodeId=5900542130c9, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2017-07-24 atomins

审稿速度:2.0 | 投稿命中率:25.0
经验分享：审稿1个月多点，被拒，回信说目前80%的拒稿率。

202 0

[GetPortalCommentsPageByObjectIdResponse(id=589406, encodeId=a3db5894067e, content=从投完稿到编辑做出决定之前一直都只显示under review152****8378暂无昵称 2020-04-21 00:00:00 发表: 想请问下，杂志显示Under review还是Under Review表示外审呢, beContent=152****8378暂无昵称 2020-04-21 00:00:00 发表: 想请问下，杂志显示Under review还是Under Review表示外审呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589397, encodeId=69ce58939eac, content=想请问下，杂志显示的Under review就是表示外审了吗？还是Under Review？183****6636暂无昵称 2020-04-06 00:00:00 发表: 感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, beContent=183****6636暂无昵称 2020-04-06 00:00:00 发表: 感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ba65088251, createdName=145c9b5bm78暂无昵称, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588314, encodeId=47b558831482, content=感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=675c2195011, createdName=120a0830m36暂无昵称, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581257, encodeId=750958125e05, content=投稿投了半年了，还没有任何消息，发了两次催稿信都说审稿人还没有返审稿意见，这审稿人是去度假还是干啥去了，坑的要死。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Tue Dec 10 00:00:00 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847865, encodeId=3a2984e865ba, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审稿挺快的，虽然分数不高，毕业用足够了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Thu Oct 25 17:12:59 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548711, encodeId=60d7548e11d0, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：7.11投.8.15一审结束.大修.说了80%拒稿.给到11.13返修结束.我10.26提交修改稿.10.28接收.感觉还是好中.关于一个良性肿瘤治疗策略的CASEs., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1dcd2010360, createdName=1e1eb212m21(暂无匿称), createdTime=Sun Oct 29 00:00:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548090, encodeId=519c548090a1, content=收稿一个多月后被拒，说拒搞率80%以上，文章内容不太符合他们主题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160527/IMG5747FCC4317196249.jpg, createdBy=f37a1729761, createdName=1dee57bam87(暂无匿称), createdTime=Tue Oct 10 17:11:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544745, encodeId=3558544e4590, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿1个月多点，被拒，回信说目前80%的拒稿率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39f52051168, createdName=atomins, createdTime=Mon Jul 24 10:56:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544744, encodeId=1b2a544e448a, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿1个月多点，被拒，回信说目前80%的拒稿率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39f52051168, createdName=atomins, createdTime=Mon Jul 24 10:56:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542130, encodeId=5900542130c9, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2017-07-24 atomins

审稿速度:2.0 | 投稿命中率:25.0
经验分享：审稿1个月多点，被拒，回信说目前80%的拒稿率。

287 0

[GetPortalCommentsPageByObjectIdResponse(id=589406, encodeId=a3db5894067e, content=从投完稿到编辑做出决定之前一直都只显示under review152****8378暂无昵称 2020-04-21 00:00:00 发表: 想请问下，杂志显示Under review还是Under Review表示外审呢, beContent=152****8378暂无昵称 2020-04-21 00:00:00 发表: 想请问下，杂志显示Under review还是Under Review表示外审呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589397, encodeId=69ce58939eac, content=想请问下，杂志显示的Under review就是表示外审了吗？还是Under Review？183****6636暂无昵称 2020-04-06 00:00:00 发表: 感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, beContent=183****6636暂无昵称 2020-04-06 00:00:00 发表: 感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ba65088251, createdName=145c9b5bm78暂无昵称, createdTime=Tue Apr 21 00:00:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588314, encodeId=47b558831482, content=感觉审稿还挺严格的一篇回顾性研究已经大修2次了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=675c2195011, createdName=120a0830m36暂无昵称, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581257, encodeId=750958125e05, content=投稿投了半年了，还没有任何消息，发了两次催稿信都说审稿人还没有返审稿意见，这审稿人是去度假还是干啥去了，坑的要死。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Tue Dec 10 00:00:00 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847865, encodeId=3a2984e865ba, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：审稿挺快的，虽然分数不高，毕业用足够了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed005413970, createdName=ms6459520362745523, createdTime=Thu Oct 25 17:12:59 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548711, encodeId=60d7548e11d0, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：7.11投.8.15一审结束.大修.说了80%拒稿.给到11.13返修结束.我10.26提交修改稿.10.28接收.感觉还是好中.关于一个良性肿瘤治疗策略的CASEs., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1dcd2010360, createdName=1e1eb212m21(暂无匿称), createdTime=Sun Oct 29 00:00:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548090, encodeId=519c548090a1, content=收稿一个多月后被拒，说拒搞率80%以上，文章内容不太符合他们主题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160527/IMG5747FCC4317196249.jpg, createdBy=f37a1729761, createdName=1dee57bam87(暂无匿称), createdTime=Tue Oct 10 17:11:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544745, encodeId=3558544e4590, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿1个月多点，被拒，回信说目前80%的拒稿率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39f52051168, createdName=atomins, createdTime=Mon Jul 24 10:56:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544744, encodeId=1b2a544e448a, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：审稿1个月多点，被拒，回信说目前80%的拒稿率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=287, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39f52051168, createdName=atomins, createdTime=Mon Jul 24 10:56:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542130, encodeId=5900542130c9, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2017-07-14 qiqi

从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有

248 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务